U.S.
Sucralfate Market, by Formulation (Tablet and Liquid Suspension), by Indication
(Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and
Others Indications), by Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York,
California, and Others) was valued at US$ 296.2 million in 2017, and is
projected to exhibit a CAGR of 3.1% over the forecast period (2018–2026), as
highlighted in a new report published by Coherent Market Insights.
Increasing product approval and
product launch by market players is expected to augment the market growth
Key players in the market and
government authorities are focused on updating the product information and
creating awareness, in order to avoid any serious side effect of sucralfate and
to address the critical unmet needs of patients. For instance, in August 2017,
Teva Pharmaceutical Industries, Ltd. and Mylan, Inc., product Carafate received
the U.S. Food and Drug Administration approval for change in the labelling
information. The warning and precaution part of labelling was updated by the
manufacturer which included the risk such as pulmonary and cerebral emboli
owing to the inappropriate administration of Carafate intravenously.
Moreover, increasing number of
prescriptions for different indications every year is expected to propel growth
of the U.S. sucralfate market. For instance, according to the Medical
Expenditure Panel Survey (MEPS) report of 2019, 2 million prescriptions of
sucralfate were sold in the U.S. in 2016 for different indications such as
stomach ulcers, gastro-esophageal reflux disease, and others.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2975
Browse 22 Market Data Tables and
17 Figures spread through 129 Pages and in-depth TOC on ‘U.S. Sucralfate
Market’- Forecast to 2026, by Formulation (Tablet and Liquid Suspension), by
Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease,
and Others Indications), by Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York,
California, and Others).
Furthermore, increasing geriatric
population and increasing incidences of gastric diseases in geriatric
population in the U.S. is expected to boost growth of the market over the
forecast period. For instance, according to the report on ‘Aging in United
States’ in 2016, the number of Americans aged 65 years and above older are
projected to double from 46 million in 2016 to over 98 million by 2060
Key Takeaways of the U.S.
Sucralfate Market:
The U.S. sucralfate market is expected
to exhibit a CAGR of 3.1% over the forecast period, owing to increasing
prevalence of peptic ulcers and duodenal in the U.S. For instance, according to
the American Association for the Study of Liver Diseases report of 2018, in the
U.S., peptic ulcer disease (PUD) affects around 4.5 million people, annually in
the U.S.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/us-sucralfate-market-2975
Among formulation, the tablet
segment held a dominant position in the U.S. sucralfate market in 2018, owing
to recommendation of tablet in various types of gastric ulcers. For instance,
sucralfate tablets are indicated for the treatment of duodenal and
non-malignant gastric ulcer. They are also indicated for prophylaxis of
duodenal ulcer recurrence.
Among distribution channel, the
retail pharmacies segment held a dominant position in the U.S. sucralfate
market in 2018, owing to increasing number of retail or independent pharmacies.
For instance, according to PLOS Journal, August 2017, the number of independent
pharmacies in the U.S. exhibited 3.8% growth from 22,737 (2007) to 23,596
(2015).
Key players operating in the U.S.
sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc,
Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2975
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment